193 related articles for article (PubMed ID: 21953276)
21. Haemoglobin A1c is not a surrogate for glucose and insulin measures for investigating the early life and childhood determinants of insulin resistance and Type 2 diabetes in healthy children. An analysis from the Avon Longitudinal Study of Parents and Children (ALSPAC).
Shultis WA; Leary SD; Ness AR; Scott J; Martin RM; Whincup PH; Smith GD;
Diabet Med; 2006 Dec; 23(12):1357-63. PubMed ID: 17116188
[TBL] [Abstract][Full Text] [Related]
22. Glycated hemoglobin in pregnancies at increased risk for gestational diabetes mellitus.
Verhaeghe J; Van Herck E; Benhalima K; Mathieu C
Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):157-62. PubMed ID: 22342592
[TBL] [Abstract][Full Text] [Related]
23. The associations of body mass index, C-peptide and metabolic status in Chinese Type 2 diabetic patients.
Chan WB; Tong PC; Chow CC; So WY; Ng MC; Ma RC; Osaki R; Cockram CS; Chan JC
Diabet Med; 2004 Apr; 21(4):349-53. PubMed ID: 15049937
[TBL] [Abstract][Full Text] [Related]
24. Relative and absolute contributions of postprandial and fasting plasma glucose to daytime hyperglycaemia and HbA(1c) in subjects with Type 2 diabetes.
Peter R; Dunseath G; Luzio SD; Chudleigh R; Choudhury SR; Owens DR
Diabet Med; 2009 Oct; 26(10):974-80. PubMed ID: 19900228
[TBL] [Abstract][Full Text] [Related]
25. Cut-off values of fasting and post-load plasma glucose and HbA1c for predicting Type 2 diabetes in community-dwelling Japanese subjects: the Hisayama Study.
Mukai N; Doi Y; Ninomiya T; Hata J; Hirakawa Y; Fukuhara M; Iwase M; Kiyohara Y
Diabet Med; 2012 Jan; 29(1):99-106. PubMed ID: 21726278
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of haemoglobin A1c and fasting plasma glucose for incident diabetes and implications for screening.
Schöttker B; Raum E; Rothenbacher D; Müller H; Brenner H
Eur J Epidemiol; 2011 Oct; 26(10):779-87. PubMed ID: 21947790
[TBL] [Abstract][Full Text] [Related]
27. Pathogenetic mechanisms and cardiovascular risk: differences between HbA(1c) and oral glucose tolerance test for the diagnosis of glucose tolerance.
Bianchi C; Miccoli R; Bonadonna RC; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo GM; Leonetti F; Del Prato S;
Diabetes Care; 2012 Dec; 35(12):2607-12. PubMed ID: 22912427
[TBL] [Abstract][Full Text] [Related]
28. Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes.
Xu L; Chan WM; Hui YF; Lam TH
Diabet Med; 2012 Mar; 29(3):393-8. PubMed ID: 21916977
[TBL] [Abstract][Full Text] [Related]
29. Relationship between mean blood glucose and glycated haemoglobin in Type 2 diabetic patients.
Makris K; Spanou L; Rambaouni-Antoneli A; Koniari K; Drakopoulos I; Rizos D; Haliassos A
Diabet Med; 2008 Feb; 25(2):174-8. PubMed ID: 18290858
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study.
Spranger J; Kroke A; Möhlig M; Hoffmann K; Bergmann MM; Ristow M; Boeing H; Pfeiffer AF
Diabetes; 2003 Mar; 52(3):812-7. PubMed ID: 12606524
[TBL] [Abstract][Full Text] [Related]
31. HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study.
Hsu CC; Chang HY; Huang MC; Hwang SJ; Yang YC; Lee YS; Shin SJ; Tai TY
Diabetologia; 2012 Dec; 55(12):3163-72. PubMed ID: 22923064
[TBL] [Abstract][Full Text] [Related]
32. Glycated hemoglobin and risk of stroke in people without known diabetes in the European Prospective Investigation into Cancer (EPIC)-Norfolk prospective population study: a threshold relationship?
Myint PK; Sinha S; Wareham NJ; Bingham SA; Luben RN; Welch AA; Khaw KT
Stroke; 2007 Feb; 38(2):271-5. PubMed ID: 17204684
[TBL] [Abstract][Full Text] [Related]
33. HbA1c measured in stored erythrocytes is positively linearly associated with mortality in individuals with diabetes mellitus.
Sluik D; Boeing H; Montonen J; Kaaks R; Lukanova A; Sandbaek A; Overvad K; Arriola L; Ardanaz E; Saieva C; Grioni S; Tumino R; Sacerdote C; Mattiello A; Spijkerman AM; van der A DL; Beulens JW; van Dieren S; Nilsson PM; Groop LC; Franks PW; Rolandsson O; Bueno-de-Mesquita B; Nöthlings U
PLoS One; 2012; 7(6):e38877. PubMed ID: 22719972
[TBL] [Abstract][Full Text] [Related]
34. Macrovascular risk and diagnostic criteria for type 2 diabetes: implications for the use of FPG and HbA(1c) for cost-effective screening.
Jesudason DR; Dunstan K; Leong D; Wittert GA
Diabetes Care; 2003 Feb; 26(2):485-90. PubMed ID: 12547886
[TBL] [Abstract][Full Text] [Related]
35. Decreasing postprandial C-peptide levels over time are not associated with long-term use of sulphonylurea: an observational study.
Nybäck-Nakell A; Bergström J; Adamson U; Lins PE; Landstedt-Hallin L
Diabetes Metab; 2010 Nov; 36(5):375-80. PubMed ID: 20579917
[TBL] [Abstract][Full Text] [Related]
36. Recent population changes in HbA(1c) and fasting insulin concentrations among US adults with preserved glucose homeostasis.
Cheng YJ; Kahn HS; Gregg EW; Imperatore G; Geiss LS
Diabetologia; 2010 Sep; 53(9):1890-3. PubMed ID: 20517591
[TBL] [Abstract][Full Text] [Related]
37. Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c The Danish Inter99 study.
Borg R; Vistisen D; Witte DR; Borch-Johnsen K
Diabet Med; 2010 Aug; 27(8):906-10. PubMed ID: 20653748
[TBL] [Abstract][Full Text] [Related]
38. Intrapersonal HbA(1c) variability and the risk of progression of nephropathy in patients with Type 2 diabetes.
Rodríguez-Segade S; Rodríguez J; García López JM; Casanueva FF; Camiña F
Diabet Med; 2012 Dec; 29(12):1562-6. PubMed ID: 22913483
[TBL] [Abstract][Full Text] [Related]
39. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes.
Farmer AJ; Perera R; Ward A; Heneghan C; Oke J; Barnett AH; Davidson MB; Guerci B; Coates V; Schwedes U; O'Malley S
BMJ; 2012 Feb; 344():e486. PubMed ID: 22371867
[TBL] [Abstract][Full Text] [Related]
40. Fasting plasma glucose and HbA1c as risk factors for Type 2 diabetes.
Inoue K; Matsumoto M; Akimoto K
Diabet Med; 2008 Oct; 25(10):1157-63. PubMed ID: 19046193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
